Background. The diagnostic and prognostic role of N‐terminal pro‐B‐type natriuretic peptide
(NT‐proBNP) in heart failure is well established. However, additional factors may influence …

Background Metabolic syndrome has been shown to be associated with lower levels of
plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP) in the general population. We …

Background: Mild stages of heart failure might be difficult to diagnose in severely obese
individuals with a body mass index (BMI)> 40 kg/m2. Measurement of the N-terminal …

Background. There are few data to demonstrate the usefulness of N-terminal pro B-type
natriuretic peptide (NT-proBNP) for the left ventricular diastolic dysfunction (LVDD) …

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is an essential biomarker for the
prediction of heart failure (HF), but its prognostic ability across body mass index (BMI) …

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be useful in the diagnosis of
heart failure and ventricular dysfunction. Obesity is an independent cardiovascular risk …

OBJECTIVE: Plasma brain natriuretic peptide (BNP) is a useful adjunct to diagnose and
monitor patient with heart failure, but there are comorbidities such as chronic kidney disease …

Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for
the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body …

Background We investigated the effect of statin treatment on the relationship between N-
terminal pro-B-type natriuretic peptide (NT-proBNP) and insulin resistance in patients …

Aims Serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) was lower in the general
population with metabolic syndrome (MetS). The aim of this study was to evaluate the …